The Healthcare Leader's Guide to Agentic AI: What It Is, What It Does, and What to Watch For
Agentic AI is the phrase appearing in every healthcare technology conversation right now. It is also, for most healthcare leaders, the least well-understood term in those conversations.
Most of the content written about agentic AI is written for technologists. This guide is written for the people who lead health systems, clinical programmes, and revenue cycle operations, the people who will be asked to approve, fund, or govern agentic AI deployments in the next 12 to 18 months and who need a clear picture of what they are actually being asked to say yes to.
What Agentic AI Actually Is
Traditional AI takes an input and produces an output. A radiologist submits an image, and the model returns a finding. A billing system runs claims through a model and flags potential errors. The human initiates the action. The AI responds. The human decides what to do with the result.
Agentic AI works differently. Instead of responding to a single input, an agent receives a goal and pursues it across multiple steps, using tools, taking actions, and making decisions along the way, often without human input at each individual step.
A practical example: A prior authorisation agent receives a request from a care coordinator. It looks up the relevant payer policy, checks the patient's clinical documentation for supporting evidence, formats and submits the request through the payer's portal, monitors for a response, and either confirms the approval or initiates an appeal if the request is denied. The care coordinator set the goal. The agent completed the work. The human's role shifted from doing each step to reviewing the outcome.
This is the fundamental distinction. Traditional AI assists with a task. An agentic system executes a task.
Where Agentic AI Is Being Deployed in Healthcare Right Now
The healthcare use cases for agentic AI that are already in production or in late-stage deployment fall into four areas.
Revenue cycle management. Agentic systems are being used to monitor claims queues, identify denials, retrieve supporting clinical documentation, draft and submit appeal letters, and track outcomes across thousands of claims simultaneously. What previously required a denial management team reviewing files one at a time can be compressed into an agentic workflow that surfaces only the cases that genuinely require human judgment.
Prior authorisation. The prior authorisation process involves a predictable set of steps, policy lookup, documentation review, submission, follow-up, that map well onto agentic workflows. Organisations that have deployed prior authorisation agents report significant reductions in the time from request to decision, along with staff time recovered from manual coordination.
Care coordination and patient outreach. Agents that monitor patient risk scores, identify gaps in care, schedule outreach, send personalised communications, and escalate patients who need human intervention are beginning to appear in both health system and payer environments. The agent does the routine monitoring and communication. The care team handles the cases the agent flags as needing direct attention.
Supply chain and procurement. Agentic systems that monitor inventory levels, predict demand based on scheduling and census data, place routine orders, and flag supplier anomalies before they become disruptions are a natural fit for the operational automation work that healthcare procurement teams have been doing manually for years.
What Makes Agentic AI Different from What Came Before
The capability that makes agentic AI genuinely different from previous automation technology is the ability to use tools and adapt to intermediate results.
A traditional automation workflow is a fixed sequence. If step three produces an unexpected result, the workflow stops, and a human intervenes. An agentic system can evaluate the result of step three, decide what to do with it, and continue. This makes agents capable of handling the variability that made full automation impractical in complex healthcare workflows.
It also makes them harder to govern. When an automation workflow produces an unexpected result, the failure point is usually traceable. When an agentic system takes an action that produces an unintended outcome, tracing why requires examining a chain of decisions the system made independently.
This is not a reason to avoid agentic AI. It is a reason to govern it properly before deployment.
The Governance Questions Every Healthcare Leader Should Be Asking
Before any agentic AI system goes into production in a healthcare environment, five governance questions need clear answers.
What is the agent authorised to do? The scope of an agent's authority needs to be defined explicitly and enforced technically. An agent deployed for prior authorisation should not be able to access systems outside its defined scope, even if the data there would be relevant to its task. Scope creep in agentic systems is a real risk, and it is controlled through design, not through trust.
What actions require human approval? Not every step in an agentic workflow should be autonomous. The boundary between what the agent handles independently and what requires a human decision should be defined before deployment. Decisions that carry significant clinical or financial consequences, a large-scale appeal submission, or a communication that changes a patient's care pathway should have human approval checkpoints built in.
Is every action auditable? Healthcare operates in a regulatory environment where the ability to demonstrate what happened, when, and why is not optional. An agentic system that cannot produce a complete, tamper-evident audit log of its actions is not deployable in a healthcare context, regardless of how capable it is.
Who is accountable when the agent makes a mistake? This question does not have a settled legal answer yet, which is exactly why health systems need to establish their own accountability frameworks before deploying agentic AI. When an agent submits an incorrect appeal or sends an inappropriate patient communication, who is responsible for the outcome? The answer needs to exist before the incident does.
What happens when the agent encounters something outside its designed scope? Every agentic system will eventually encounter an input it was not designed for. The response to that situation, stopping, escalating to a human, or attempting to handle it anyway, needs to be specified and tested before go-live.
What to Watch For Over the Next 18 Months
Agentic AI in healthcare is moving faster than the governance frameworks designed to manage it. Several developments are worth monitoring closely.
Regulatory attention is increasing. The FDA's approach to AI-enabled medical devices and the Office for Civil Rights' attention to AI-related HIPAA considerations are both evolving. Healthcare organisations that build governance infrastructure now will be in a stronger position when regulatory requirements arrive than those that build it in response to enforcement.
Multi-agent systems are emerging. The next wave of agentic deployment is not single agents but networks of agents, systems where one agent coordinates others, each specialised for a different task. A care coordination agent that can call a scheduling agent, a communication agent, and a documentation agent simultaneously is more capable than any of those systems individually. It is also significantly more complex to govern.
The vendor accountability question is becoming urgent. Most healthcare technology contracts were not written with agentic AI in mind. As health systems deploy agents built on vendor platforms, the question of where vendor accountability ends and health system accountability begins is increasingly unclear. Contracts negotiated today should address this explicitly.
Clinical agentic AI is coming faster than most organisations are ready for. The current wave of healthcare agentic deployment is primarily operational, revenue cycle, supply chain, and administrative coordination. Clinical agentic AI, agents that monitor patients, flag deterioration, and trigger clinical responses, is in development across multiple platforms. The governance requirements for clinical agents are substantially higher than for operational ones, and most health systems are not yet prepared.
The Practical Starting Point
Healthcare leaders who want to position their organisations to benefit from agentic AI without taking on unacceptable risk should focus on three things.
Build the governance infrastructure before the first deployment. That means defining scope boundaries, establishing audit requirements, creating accountability frameworks, and developing a response process for agent failures, all before a vendor contract is signed.
Start with operational use cases that have clear boundaries and measurable outcomes.
Revenue cycle, prior authorisation, and supply chain are lower-risk starting points than clinical applications, and the outcomes are easier to measure. Early deployments that succeed build the organisational confidence and technical capability for what comes next.
Treat agentic AI as a programme decision, not a project decision. An organisation that deploys one agent in one department and learns from it is in a very different position 18 months from now than an organisation that deploys multiple agents without a coordinating governance framework. The architecture decisions made in the first deployment shape every deployment that follows.
Agentic AI is not a future technology. It is a technology in active deployment across healthcare right now. The organisations that govern it thoughtfully will get the capability without the consequences. The ones that do not will discover the governance requirements the hard way.
Comments